Çѱ¹À¯¹æ¾ÏÇÐȸ Á¦18ȸ Ç׾Ͽä¹ý ½ÉÆ÷Áö¾ö : 2022-03-26±³À°ÀÏÀÚ : 2022-03-26
±³À°Àå¼Ò : ¼¿ïµå·¡°ï½ÃƼ 5Ãþ ±×·£µåº¼·ë ¹éµÎȦ
±³À°ÁÖÁ¦ :
Á¦18ȸ Ç׾Ͽä¹ý ½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : Çѱ¹À¯¹æ¾ÏÇÐȸ
´ã´çÀÚ : Á¤Áö¿µ
¿¬¶ôó : 02-3461-6060
À̸ÞÀÏ :
kbcs@kbcs.or.kr ±³À°Á¾·ù : ³»°ú, ¿Ü°ú
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 5 ½Ã°£ 15ºÐ
¼¼ºÎ¼ö°·á : 80,000¿ø
ºñ°í Á¤È¸¿ø.ÁØȸ¿ø : 5¸¸¿ø / °£È£»ç.Àü°øÀÇ : 3¸¸¿ø / ºñȸ¿ø : 8¸¸¿ø / 65¼¼ÀÌ»ó : ¹«·á
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-26 ¹éµÎȦ 09:10~09:35 Clinical Applications of Gene Expression Signatures in HR+/HER2- Early Breast Cancer À¯Á¾ÇÑ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 03-26 ¹éµÎȦ 09:35~10:00 Emerging Adjuvant Therapies in HR+/HER2- Early Breast Cancer : Are we ready for prime time? ¼ÕÁÖÇõ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 03-26 ¹éµÎȦ 10:00~10:25 Systemic treatment in HR+/HER2- Metastatic Breast Cancer : Current status & Future perspectives ÀÓ½ÂÅÃ(¿¬¼¼ÀÇ´ë)
Åä·Ð 03-26 ¹éµÎȦ 10:25~10:35 Discussion ()
ÈÞ½Ä 03-26 10:35~10:50 Break ()
±³À°½Ã°£ 03-26 ¹éµÎȦ 10:50~11:15 Tailored approaches in Neoadjuvant/Adjuvant Systemic Therapy : Escalation vs. De-escalation ¾È¼º±Í(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 03-26 ¹éµÎȦ 11:15~11:40 Optimize Metastatic HER2+ Breast Cancer with Several anti-HER2 Treatment ¹Ú°æÈ(°í·ÁÀÇ´ë)
Åä·Ð 03-26 ¹éµÎȦ 11:40~11:50 Discussion ()
½Ä»ç 03-26 11:50~12:50 Lunch ()
±³À°½Ã°£ 03-26 ¹éµÎȦ 12:50~13:15 Recent advances in Neoadjuvant/Adjuvant Chemotherapy : Immunotherapy, Chemotherapy ¿øÇý¼º(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 03-26 ¹éµÎȦ 13:15~13:40 Immune Checkpoint Inhibition for Metastatic TNBC : Is there an optimal combination? À̼öÀÌ(µ¿¾ÆÀÇ´ë)
±³À°½Ã°£ 03-26 ¹éµÎȦ 13:40~14:05 Biomarker-driven therapeutic approaches in Metastatic TNBC äÀǼö(°æºÏÀÇ´ë)
Åä·Ð 03-26 ¹éµÎȦ 14:05~14:15 Discussion ()
ÈÞ½Ä 03-26 14:15~14:30 Break ()
±³À°½Ã°£ 03-26 ¹éµÎȦ 14:30~14:55 Breast Cancer in Pregnancy ¹è¼ö¿¬(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 03-26 ¹éµÎȦ 14:55~15:20 Patients with Cardiac risk factors Á¤¿ì¹é(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 03-26 ¹éµÎȦ 15:20~15:45 Systemic Treatment in Older Patients ±èÁöÇü(¿¬¼¼ÀÇ´ë)
Åä·Ð 03-26 15:45~15:55 Discussion ()